Protagenic Therapeutics, Inc.\new (PTIX): Revenue

Annual figures by period end, from SEC filings.

Partial revenue. In this company's filings, reported revenue for the year ended 2026-03-31 is zero or negative beside a profit. The revenue it tags covers only part of its income (banks and REITs often tag only fee income this way, leaving out interest or rent), so it is not the company's whole top line. Margins on it are not computed, and it is left out of revenue rankings.

$0
Year ended 2026-03-31
Period endedRevenueChange YoYSource filing
2026-03-31$0n/a2026-08-14, From 2025-04-01
2025-03-31$0n/a2026-08-14, From 2024-04-01
No annual figure between 2023-12-31 and 2025-03-31.
2023-12-31$0n/a2025-03-31, From 2023-01-01
2022-12-31$0n/a2024-05-14, From 2022-01-01
2021-12-31$0n/a2023-03-31, From 2021-01-01
2020-12-31$0n/a2022-04-07, From 2020-01-01
No annual figure between 2016-12-31 and 2020-12-31.
2016-12-31$0n/a2017-05-08, From 2016-01-01
2015-12-31$0n/a2017-05-08, From 2015-01-01
No annual figure between 2014-06-30 and 2015-12-31.
2014-06-30$0n/a2014-10-14, From 2013-07-12